New Publication: Patients’ Guide to Biologic Treatment Options

New Publication: Patients’ Guide to Biologic Treatment Options

Recent advances in biologic medicines have revolutionized the treatment of many illnesses and conditions, from cancer to autoimmune diseases and many others. The FDA is also approving an increasing number of biologic treatments – including biosimilars –...

New Series: THE LAST WORD

As part of the Patient Access and Affordability Project’s ongoing work to hold ICER accountable, we are pleased to announce a new report series, “The Last Word.” In this series, Dr. Paul Langley dissects and refutes the conclusions in ICER’s...